For example, it is still unclear how CGG expansion leads to epigenetic gene silencing of the FMR1 gene, how the loss-of-function of FMRP leads to neural deficits in FXS fetuses, or how the CGGs become extensively unstable in patients. This evidence concerns the gene FMR1 and fragile X syndrome.